NDC 57844-510
Adasuve
Loxapine
Adasuve is a Respiratory (inhalation) Aerosol, Powder in the Human Prescription Drug category. It is labeled and distributed by Teva Select Brands. The primary component is Loxapine.
| Product ID | 57844-510_f34da003-6601-4cf7-8036-b65d3c6606ea |
| NDC | 57844-510 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Adasuve |
| Generic Name | Loxapine |
| Dosage Form | Aerosol, Powder |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2014-01-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022549 |
| Labeler Name | Teva Select Brands |
| Substance Name | LOXAPINE |
| Active Ingredient Strength | 10 mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 57844-510-55
5 POUCH in 1 CARTON (57844-510-55) > 1 AEROSOL, POWDER in 1 POUCH (57844-510-11)
| Marketing Start Date | 2014-01-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 57844-510-75 [57844051075]
Adasuve AEROSOL, POWDER
| Marketing Category | NDA |
| Application Number | NDA022549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-10-24 |
| Marketing End Date | 2017-06-06 |
NDC 57844-510-71 [57844051071]
Adasuve AEROSOL, POWDER
| Marketing Category | NDA |
| Application Number | NDA022549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-10-10 |
| Marketing End Date | 2017-06-06 |
NDC 57844-510-55 [57844051055]
Adasuve AEROSOL, POWDER
| Marketing Category | NDA |
| Application Number | NDA022549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-01-22 |
| Marketing End Date | 2018-01-31 |
NDC 57844-510-11 [57844051011]
Adasuve AEROSOL, POWDER
| Marketing Category | NDA |
| Application Number | NDA022549 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-01-22 |
| Marketing End Date | 2018-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LOXAPINE | 10 mg/1 |
OpenFDA Data
| SPL SET ID: | b074f950-246a-41f0-aedf-32f38998a4b1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
NDC Crossover Matching brand name "Adasuve" or generic name "Loxapine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10885-003 | Adasuve | loxapine |
| 51097-001 | Adasuve | loxapine |
| 57844-510 | Adasuve | Adasuve |
| 0378-7005 | Loxapine | loxapine |
| 0378-7010 | Loxapine | loxapine |
| 0378-7025 | Loxapine | loxapine |
| 0378-7050 | Loxapine | loxapine |
| 0527-1394 | Loxapine | Loxapine |
| 0527-1395 | Loxapine | Loxapine |
| 0527-1396 | Loxapine | Loxapine |
| 0527-1397 | Loxapine | Loxapine |
| 0591-0369 | Loxapine | Loxapine |
| 0591-0370 | Loxapine | Loxapine |
| 0591-0371 | Loxapine | Loxapine |
| 0591-0372 | Loxapine | Loxapine |
| 17856-1397 | Loxapine | Loxapine |
| 35573-436 | Loxapine | Loxapine |
| 35573-437 | Loxapine | Loxapine |
| 35573-438 | Loxapine | Loxapine |
| 35573-439 | Loxapine | Loxapine |
| 50090-3099 | Loxapine | Loxapine |
| 50090-3457 | Loxapine | loxapine |
| 50090-4701 | Loxapine | Loxapine |
| 51079-901 | Loxapine | loxapine |
| 51079-902 | Loxapine | loxapine |
| 51079-903 | Loxapine | loxapine |
Trademark Results [Adasuve]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ADASUVE 77752342 4276060 Live/Registered |
Alexza Pharmaceuticals, Inc. 2009-06-04 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.